Skip to main content

Bingham Kate's Form 4 filing

Bicycle Therapeutics PLC (BCYC) · filed Jul 15, 2021

Accession no.
0000899243-21-028546
Filed
Jul 15, 2021
Trade date
Jul 13-14, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions. Open-market sales total $1.53M. It was filed 2 days after the trade.

This filing was later replaced by the amendment 0000899243-21-028984 (Jul 20, 2021). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bingham KateCIK 0001185040Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 13, 2021Ordinary SharesSSaleDisposed−588$33.50−$19,6981,875,049Indirect
Jul 14, 2021Ordinary SharesSSaleDisposed−43,378$34.01−$1,475,285.781,831,671Indirect
Jul 13, 2021Ordinary SharesSSaleDisposed−12$33.50−$40239,625Indirect
Jul 14, 2021Ordinary SharesSSaleDisposed−917$34.01−$31,187.1738,708Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)